| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Amneal Pharmaceuticals, Inc. (AMRX) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 5 sells. AMRX is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 291.0K | $4.69M | - | |
| Dir | 225.4K | $3.63M | - | |
| VP | 152.4K | $2.46M | - | |
| VP | 146.4K | $2.36M | - | |
| CFO | 122.2K | $1.97M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 6, 2019 | Terreri Peter R | Director | Sale+OE | 23,345 | $12.39 | $289,244.55 | -48.1% | |
| Aug 21, 2018 | Shah Nikita53 | SVP, Chief Hr Officer | Sell | 50,000 | $23.46 | $1,173,000.00 | -23.1% | |
| Aug 21, 2018 | Reasons Bryan M. | CFO | Sell | 11,698 | $23.65 | $276,657.70 | -12.4% | |
| May 4, 2018 | Aphc Holdings, LLC | 10% Owner | Sell | 46,849,316 | $18.25 | $855,000,017.00 | -87.2% |